(Reuters) -Philips reported second-quarter outcomes that beat analysts’ expectations on Monday, boosted by increased earnings and the implementation of its restructuring program.
The Dutch-based medical devise maker’s adjusted earnings earlier than curiosity, tax and amortisation (EBITA) reached 495 million euros ($537.4 million), beating the 433 million euros anticipated by analysts in a company-compiled ballot.
Adjusted EBITA margin rose to 11.1% of gross sales, in contrast with 10.1% in the identical interval final 12 months.
“We achieved sturdy margin enchancment, supported by our productiveness program, stable operational cashflow because of improved working capital administration and comparable gross sales development in step with our plan,” stated CEO Roy Jakobs in a press release.
The group reiterated its monetary targets for the remainder of the 12 months.
($1 = 0.9211 euros)
